Pregled bibliografske jedinice broj: 1111084
Pharmacist’s intervention in pharmacotherapy treatment of Helicobacter pylori – a case report
Pharmacist’s intervention in pharmacotherapy treatment of Helicobacter pylori – a case report // VI Kongres Farmaceuta Srbije s međunarodnim sudjelovanjem Knjiga sažetaka
Beograd, Srbija, 2014. str. 305-305 (poster, međunarodna recenzija, sažetak, stručni)
CROSBI ID: 1111084 Za ispravke kontaktirajte CROSBI podršku putem web obrasca
Naslov
Pharmacist’s intervention in pharmacotherapy
treatment of Helicobacter pylori – a case report
Autori
Falamić, Slaven ; Samardžić, Ivana ; Smontara, Sanja ; Bačić Vrca, Vesna
Vrsta, podvrsta i kategorija rada
Sažeci sa skupova, sažetak, stručni
Izvornik
VI Kongres Farmaceuta Srbije s međunarodnim sudjelovanjem Knjiga sažetaka
/ - , 2014, 305-305
Skup
VI Kongres farmaceuta Srbije s međunarodnim sudjelovanjem
Mjesto i datum
Beograd, Srbija, 15.10.2014. - 19.10.2014
Vrsta sudjelovanja
Poster
Vrsta recenzije
Međunarodna recenzija
Ključne riječi
helicobacter pylori, pharmacist interventions
Sažetak
Pharmacists present the last professional supervision in the medication cycle and have a great responsibility in preventing medication errors. Herein, we present a case of a successful pharmacist’s intervention in eradicating Helicobacter pylori (H. pylori) infection - the main cause of gastritis, gastroduodenal ulcer disease, gastric adenocarcinoma and mucosa- associated tissue lymphoma. Eradication of H. pylori is a very sensitive process and requires a thorough adherence to guidelines. A 28 year old female diagnosed with H. pylori infection was assingned by her physician with the following therapy: esomeprazole 40 mg q.d., metronidazole 400 mg b.i.d and ciprofloxacin 500 mg b.i.d. While taking the medication review, the pharmacist found this to be the second eradication protocol as the first treatment protocol consisting of pantoprasole 40 mg q.d., claritromycin 500 mg b.i.d. and amoxicilin 1000 mg b.i.d. failed to give results after seven days of treatment. The pharmacist suggested the following therapy modification to patient's physician based on the guidelines for the treatment of H. Pylori: proton pump inhibitor dose increase (q.d. to b.i.d.) and extending the eradication regimen to 14 days. After completion of the modified eradication protocol the patient was cured. Pharmacist’ intervention contributed to successful H. pylori eradication. Awareness of possible medication errors throughout the medication cycle is crucial as it can improve the therapeutic goal and reduce the cost of treatment.
Izvorni jezik
Engleski
Znanstvena područja
Farmacija
